Welcome!

News Feed Item

Influenza Global Clinical Trials Review, H2, 2013



 

 

 

LONDON, March 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Influenza Global Clinical Trials Review, H2, 2013


Influenza Global Clinical Trials Review, H2, 2013


Summary

GlobalData's clinical trial report, "Influenza Global Clinical Trials Review, H2, 2013" provides data on the Influenza clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Influenza. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Influenza 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Influenza 24
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Influenza Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Sanofi 56
Clinical Trial Overview of Sanofi 56
MedImmune, LLC 61
Clinical Trial Overview of MedImmune, LLC 61
F. Hoffmann-La Roche Ltd. 65
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 65
CSL Limited 67
Clinical Trial Overview of CSL Limited 67
Baxter International Inc. 69
Clinical Trial Overview of Baxter International Inc. 69
Daiichi Sankyo Company, Limited 71
Clinical Trial Overview of Daiichi Sankyo Company, Limited 71
Crucell Holland B.V 72
Clinical Trial Overview of Crucell Holland B.V 72
BioCryst Pharmaceuticals, Inc. 73
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 73
Adimmune Corporation 74
Clinical Trial Overview of Adimmune Corporation 74
Sinovac Biotech Co., Ltd. 75
Clinical Trial Overview of Sinovac Biotech Co., Ltd. 75
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Clinical Trial Overview of OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Novartis Vaccines and Diagnostics, Inc. 77
Clinical Trial Overview of Novartis Vaccines and Diagnostics, Inc. 77
Novavax, Inc. 78
Clinical Trial Overview of Novavax, Inc. 78
VaxInnate Corporation 79
Clinical Trial Overview of VaxInnate Corporation 79
Protein Sciences Corporation 80
Clinical Trial Overview of Protein Sciences Corporation 80
Abbott Laboratories 81
Clinical Trial Overview of Abbott Laboratories 81
Kaketsuken K.K. 82
Clinical Trial Overview of Kaketsuken K.K. 82
Pfizer Inc. 83
Clinical Trial Overview of Pfizer Inc. 83
Clinical Trial Overview of Top Institutes / Government 84
The National Institute of Allergy and Infectious Diseases 84
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 84
The University of Hong Kong 91
Clinical Trial Overview of The University of Hong Kong 91
University of Oxford 92
Clinical Trial Overview of University of Oxford 92
University Hospitals of Leicester NHS Trust 93
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 93
National Hospital Organization Mie National Hospital 94
Clinical Trial Overview of National Hospital Organization Mie National Hospital 94
Centers for Disease Control and Prevention 95
Clinical Trial Overview of Centers for Disease Control and Prevention 95
St. Jude Children's Research Hospital, Inc. 96
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 96
The University of British Columbia 97
Clinical Trial Overview of The University of British Columbia 97
University of the Witwatersrand 98
Clinical Trial Overview of University of the Witwatersrand 98
Program for Appropriate Technology in Health 99
Clinical Trial Overview of Program for Appropriate Technology in Health 99
University of Rochester 100
Clinical Trial Overview of University of Rochester 100
Columbia University 101
Clinical Trial Overview of Columbia University 101
Assistance Publique - Hopitaux de Paris 102
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 102
McMaster University 103
Clinical Trial Overview of McMaster University 103
Institut National de la Sante et de la Recherche Medicale 104
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 104
Queen Mary Hospital 105
Clinical Trial Overview of Queen Mary Hospital 105
University of Pittsburgh 106
Clinical Trial Overview of University of Pittsburgh 106
Hadassah Medical Organization 107
Clinical Trial Overview of Hadassah Medical Organization 107
University of Michigan 108
Clinical Trial Overview of University of Michigan 108
University of Alberta 109
Clinical Trial Overview of University of Alberta 109
Five Key Clinical Profiles 110
Appendix 161
Abbreviations 161
Definitions 161
Research Methodology 162
Secondary Research 162
About GlobalData 163
Contact Us 163
Disclaimer 163
Source 164




List of Tables

Influenza Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries, 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries, 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Influenza Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Influenza Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 37
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 49
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 56
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2013* 61
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 65
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2013* 67
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2013* 69
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 71
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell Holland B.V, 2013* 72
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2013* 73
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Adimmune Corporation, 2013* 74
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sinovac Biotech Co., Ltd., 2013* 75
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd., 2013* 76
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Vaccines and Diagnostics, Inc., 2013* 77
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2013* 78
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by VaxInnate Corporation, 2013* 79
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Protein Sciences Corporation, 2013* 80
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 81
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaketsuken K.K., 2013* 82
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 83
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 84
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2013* 91
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 92
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2013* 93
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2013* 94
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2013* 95
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2013* 96
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2013* 97
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Witwatersrand, 2013* 98
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Program for Appropriate Technology in Health, 2013* 99
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 100
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 101
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 102
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013* 103
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2013* 104
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2013* 105
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 106
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 107
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 108
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2013* 109

List of Figures
Influenza Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
GlobalData Methodology 162


Read the full report:
Influenza Global Clinical Trials Review, H2, 2013
http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trial...

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
SYS-CON Events announced today that StarNet Communications will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. StarNet Communications’ FastX is the industry first cloud-based remote X Windows emulator. Using standard Web browsers (FireFox, Chrome, Safari, etc.) users from around the world gain highly secure access to applications and data hosted on Linux-based servers in a central data center. ...
Smart Cities are here to stay, but for their promise to be delivered, the data they produce must not be put in new siloes. In his session at @ThingsExpo, Mathias Herberts, Co-founder and CTO of Cityzen Data, will deep dive into best practices that will ensure a successful smart city journey.
SYS-CON Events announced today that 910Telecom will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Housed in the classic Denver Gas & Electric Building, 910 15th St., 910Telecom is a carrier-neutral telecom hotel located in the heart of Denver. Adjacent to CenturyLink, AT&T, and Denver Main, 910Telecom offers connectivity to all major carriers, Internet service providers, Internet backbones and ...
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
StarNet Communications Corp has announced the addition of three Secure Remote Desktop modules to its flagship X-Win32 PC X server. The new modules enable X-Win32 to safely tunnel the remote desktops from Linux and Unix servers to the user’s PC over encrypted SSH. Traditionally, users of PC X servers deploy the XDMCP protocol to display remote desktop environments such as the Gnome and KDE desktops on Linux servers and the CDE environment on Solaris Unix machines. XDMCP is used primarily on comp...
Almost two-thirds of companies either have or soon will have IoT as the backbone of their business in 2016. However, IoT is far more complex than most firms expected. How can you not get trapped in the pitfalls? In his session at @ThingsExpo, Tony Shan, a renowned visionary and thought leader, will introduce a holistic method of IoTification, which is the process of IoTifying the existing technology and business models to adopt and leverage IoT. He will drill down to the components in this fra...
Why do your mobile transformations need to happen today? Mobile is the strategy that enterprise transformation centers on to drive customer engagement. In his general session at @ThingsExpo, Roger Woods, Director, Mobile Product & Strategy – Adobe Marketing Cloud, covered key IoT and mobile trends that are forcing mobile transformation, key components of a solid mobile strategy and explored how brands are effectively driving mobile change throughout the enterprise.
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - comp...
As the world moves toward more DevOps and Microservices, application deployment to the cloud ought to become a lot simpler. The Microservices architecture, which is the basis of many new age distributed systems such as OpenStack, NetFlix and so on, is at the heart of Cloud Foundry - a complete developer-oriented Platform as a Service (PaaS) that is IaaS agnostic and supports vCloud, OpenStack and AWS. Serverless computing is revolutionizing computing. In his session at 19th Cloud Expo, Raghav...
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, will discuss the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
There is growing need for data-driven applications and the need for digital platforms to build these apps. In his session at 19th Cloud Expo, Muddu Sudhakar, VP and GM of Security & IoT at Splunk, will cover different PaaS solutions and Big Data platforms that are available to build applications. In addition, AI and machine learning are creating new requirements that developers need in the building of next-gen apps. The next-generation digital platforms have some of the past platform needs a...